Intravenous drug abusers have become the largest source of heterosexual transmission of AIDS. Since their risk-taking behavior has been extremely resistant to change, it is imperative that we become more successful in the treatment of i.v. drug abuse if we are to focus on AIDS prevention. The currently proposed research investigates problems relevant to understanding and treating uncontrolled cocaine use, concentrating on the intravenous route of administration, and evaluating the behavioral mechanisms of action of a number of pharmacological agents proposed for the treatment of cocaine abuse. This is especially relevant since i.v. cocaine use may be even more likely than heroin to contribute to HIV infection. Minimal data exist on the relationship between cocaine-taking and maintenance on a variety of pharmaceutical substances proposed as possible treatment agents for cocaine abusers. This research will evaluate cocaine-taking behavior as well as its subjective effects, including """"""""craving,"""""""" and physiological effects before and during maintenance on carbamazepine, mazindol and sertraline, three currently proposed treatment agents. As newer agents are proposed, they, too, will be evaluated. Evaluations will be carried out under conditions in which subjects will have a broad range of behavioral options including cocaine- taking, and measures in shifts in choice of these options will be made. Since cocaine abstinence is the most desired treatment outcome, laboratory procedures in which the behavior of cocaine self-administration is specifically measured under conditions with some comparability to those outside of the laboratory show the most promise as a laboratory model for assessment of potential pharmacotherapeutic agents. Such a model would enable faster development of promising agents, reserving costlier and arduous double blind trials for those most potentially useful and as well, providing considerably more information about the behavioral mechanisms of action of the compounds being tested because of the careful laboratory control possible.
| Kalapatapu, Raj K; Bedi, Gillinder; Haney, Margaret et al. (2012) Substance use after participation in laboratory studies involving smoked cocaine self-administration. Drug Alcohol Depend 120:162-7 |
| Kalapatapu, Raj K; Bedi, Gillinder; Haney, Margaret et al. (2012) The subjective effects of cocaine: relationship to years of cocaine use and current age. Am J Drug Alcohol Abuse 38:530-4 |
| Kalapatapu, Raj K; Vadhan, Nehal P; Rubin, Eric et al. (2011) A pilot study of neurocognitive function in older and younger cocaine abusers and controls. Am J Addict 20:228-39 |
| Haney, Margaret; Rubin, Eric; Foltin, Richard W (2011) Aripiprazole maintenance increases smoked cocaine self-administration in humans. Psychopharmacology (Berl) 216:379-87 |
| Vosburg, Suzanne K; Hart, Carl L; Haney, Margaret et al. (2010) Modafinil does not serve as a reinforcer in cocaine abusers. Drug Alcohol Depend 106:233-6 |
| Hart, Carl L; Haney, Margaret; Vosburg, Suzanne K et al. (2008) Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33:761-8 |
| Comer, S D; Ashworth, J B; Foltin, R W et al. (2008) The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96:1-15 |
| Hart, Carl L; Haney, Margaret; Vosburg, Suzanne K et al. (2007) Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol 18:71-5 |
| Zernig, Gerald; Ahmed, Serge H; Cardinal, Rudolf N et al. (2007) Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80:65-119 |
| Hart, Carl L; Haney, Margaret; Collins, Eric D et al. (2007) Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend 86:274-7 |
Showing the most recent 10 out of 31 publications
